Enzyvant Therapeutics GmbH

 Enzyvant Therapeutics GmbH contact information is shown below
Owner:ENZYVANT THERAPEUTICS GMBH
Owner Address:Viaduktstrasse 8 Basel 4051 Switzerland
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byEnzyvant Therapeutics GmbH

Brand:

ENTHYMIC

Description:

Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto;

Category: PHARMACEUTICAL PREPARATIONS HUMAN USE
Brand:

ENZYVANT

Description:

Pharmaceutical and biological preparations used in the treatment of rare or metabolic conditions, disorders and diseases;

Category: PHARMACEUTICAL BIOLOGICAL PREPARATIONS USED
Brand:

ENZYVANT

Description:

Providing health and medical information; providing a website featuring information about pharmaceutical drugs;

Category: PROVIDING HEALTH MEDICAL INFORMATION
Brand:

ENZYVANT

Description:

The mark consists of a design of ovals forming two concentric circles with the wording ENZYVANT appearing to the right of the design.;Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto;Color is not claimed as a feature of the mark.;Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions;Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials;

Category: